Dystocia Emergencies (Proceedings PDF)

Medicus Pharma submitted a product development plan to the FDA for an Investigational New Animal Drug designation.

Marcy Bliss, CEO of Wedgewood Pharmacy, talks GFI #256 compliance and how drug compounding has changed over time

As equine veterinarians and advocates work to ensure their patient-athletes are receiving proper care, scientists work to advance therapies and better understand their physiology

In this episode of The Vet Blast Podcast, Jennifer Vitucci, DVM, CCRT, discusses innovations that allow small animals to benefit from shock wave technology without the need for sedation

This skeletal muscle infection is best managed in a hospital

The new guidelines will address 2 viral causes of liver damage impact equine patients